Navigation Links
Urban Monkeys Source Of Virus Infections

Asian Urban monkeys may be a source of various pathogenic viruses and the transmission of these viruses to humans are high due to contacts of humans with monkeys. Researchers from University of Washington// have undergone a test of isolation of different viruses from 20 urban macaques and the test results showed that more than 10 macques harbored retroviruses. The results indicate that contact with performing monkeys, which is common in many Asian countries, could represent a little-known path for viruses to jump the species barrier from monkeys to humans and eventually cause human disease. It is known that HIV in humans, is believed to have originated as a primate virus and jumped the species barrier to humans when African bushmeat hunters came into contact with blood from infected animals.

The Researchers found that about half of the macaques tested positive for simian foamy virus (SFV), a primate retrovirus that so far has not been shown to cause disease in humans, but that has been detected in other monkey-human interaction settings in Asia. Two of the monkeys tested positive for simian retrovirus (SRV), which, though it has been shown to infect humans in a laboratory setting, has yet to be associated with any disease in humans. However, both SRV and SFV are retroviruses, which are typically slow-acting in their host, so it could be many years before physicians know the effects of those virus exposures. One monkey tested positive for simian T-cell lymphotropic virus (STLV), which is believed to be the primate ancestor to the human version of the virus, HTLV, a known cause of T-cell leukemia in people. One macaque tested positive for herpes B virus, also known as CHV-1, which rarely infects humans, but, in the 40 known human cases, was associated with an 80 percent fatality rate.

The researchers urge the monkey perfromers to take precautions around performing monkeys, by preventing the animals from climbing on them and by keeping food away fro
'"/>




Page: 1 2

Related medicine news :

1. Urban Built Environment May Play a Vital Role in Influencing the Body Size
2. ISB To Establish Research Chair On Real Estate And Urban Studies
3. Stress and Pollution are Major Cause of Infertility Among Urban Couples
4. Cartoons to Indicate Aggressiveness in Urban School Girls
5. Urban Women , Beware Of Bulimia !!
6. Telephone Outreach Boost CRC Screening In Urban Minority
7. Urban Poor in Dire Need of Proper Healthcare: Report
8. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
9. Monkeys offer genetic clues to adult blindness
10. Monkeys Respond To HIV Treatment
11. Drug Company Admits Knowledge Of Side Effects In Monkeys
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Urban Monkeys Source Virus Infections

Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6New Robotic Arm Has Softer Surgical Touch 55753 1New Robotic Arm Has Softer Surgical Touch 55753 2Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 1Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 2Nielsen Announces Final Entry Deadline Extension of September 10th for the First Ever CLIO Healthcare Awards 55750 3Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 1Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 2Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 3
Other Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 5Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 6Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 7Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 8Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 9Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 10Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture 11Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2